US FDA to strictly monitor sale of flavoured e-cigarettes
The new policy will apply to flavoured cartridge-style vaping products like Juul that have become popular among youths, not the open tank-style systems sold in vape shops and mostly used by adults, officials said
New Delhi: The US Food and Drug Administration plans to require strict limits on the sale of most flavoured e-cigarettes, including age verification controls for online sales, in an effort to curtail their use among children and teenagers. FDA officials told The Wall Street Journal on November 8, the actions are expected to be announced as early as next week.
The move is an attempt to curb what many are saying is an epidemic of underage vaping.
"What I can't tolerate is another year of this level of growth," FDA Commissioner Scott Gottlieb said in an interview on November 7.
The new policy will apply to flavoured cartridge-style vaping products like Juul that have become popular among youths, not the open tank-style systems sold in vape shops and mostly used by adults, officials said
No retail outlets will be allowed to carry them unless it restricts minors from entering the store or creates an off-limits area.
Since 2017, FDA officials had discussed e-cigarettes as a potential tool to wean adult smokers off cigarettes, but in September the FDA reversed course and warned the industry to address the problem of surging teenage e-cigarette use or risk having their flavoured products pulled off the market.
Gottlieb said then that the agency did not predict an "epidemic addiction" among youth, mainly driven by flavoured products.
The FDA's new restrictions were earlier reported by The Washington Post.
Also on November 8, New York Gov. Andrew Cuomo's administration announced plans to ban the sale of flavoured e-cigarettes as soon as next year, possibly making his state the first to prohibit such vaping products often marketed as a safer alternative to traditional cigarettes.
Read Also: FDA protects kids from illegal sales of e-cigarettes, e-liquids and cigars
New Delhi: The US Food and Drug Administration plans to require strict limits on the sale of most flavoured e-cigarettes, including age verification controls for online sales, in an effort to curtail their use among children and teenagers. FDA officials told The Wall Street Journal on November 8, the actions are expected to be announced as early as next week.
The move is an attempt to curb what many are saying is an epidemic of underage vaping.
"What I can't tolerate is another year of this level of growth," FDA Commissioner Scott Gottlieb said in an interview on November 7.
The new policy will apply to flavoured cartridge-style vaping products like Juul that have become popular among youths, not the open tank-style systems sold in vape shops and mostly used by adults, officials said
No retail outlets will be allowed to carry them unless it restricts minors from entering the store or creates an off-limits area.
Since 2017, FDA officials had discussed e-cigarettes as a potential tool to wean adult smokers off cigarettes, but in September the FDA reversed course and warned the industry to address the problem of surging teenage e-cigarette use or risk having their flavoured products pulled off the market.
Gottlieb said then that the agency did not predict an "epidemic addiction" among youth, mainly driven by flavoured products.
The FDA's new restrictions were earlier reported by The Washington Post.
Also on November 8, New York Gov. Andrew Cuomo's administration announced plans to ban the sale of flavoured e-cigarettes as soon as next year, possibly making his state the first to prohibit such vaping products often marketed as a safer alternative to traditional cigarettes.
Read Also: FDA protects kids from illegal sales of e-cigarettes, e-liquids and cigars
Next Story
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd